Profile
| Metric | Value |
|---|---|
| Full Name | CureVac N.V. |
| Ticker | NASDAQ: CVAC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Germany |
| IPO | |
| Indexes | Not included |
| Website | curevac.com |
| Employees | 825 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $4.66 | |
| Price, 1D Change | - | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | 6.52 | |
| Beta | 0.93 | |
| Revenue | $579M | |
| Revenue, 1Y Change | +896.07% | |
| EPS | $0.78 | |
| EPS, 1Y Change | +161.39% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.78 | |
| EPS Estimate | - | |
| EPS Est. Change | - | |
| Revenue | $578.90M | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $4.66 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.03 | -$1.27 | -23.66% | |
| $0.84 | $0.78 | -6.65% | |
| - | N/A | - | |
| -$0.50 | N/A | -163.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $59.34M | $58.12M | -2.06% | |
| $524.17M | $578.90M | +10.44% | |
| - | N/A | - | |
| $88.19M | N/A | -84.77% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +18.27% | |
| Price, 3Y | -54.49% | |
| Market Cap, 1Y | +18.71% | |
| Market Cap, 3Y | -47.44% | |
| Revenue, 1Y | +896.07% | |
| Revenue, 3Y | +375.55% | |
| EPS, 1Y | +161.39% | |
| EPS, 3Y | +129.89% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $4.66 | |
| SMA 200 | $4.77 | |
| SMA 200 vs Price | +2.39% | |
| SMA 50 | $5.00 | |
| SMA 50 vs Price | +7.38% | |
| Beta | 0.93 | |
| ATR | $0.14 | |
| 14-Day RSI | 47.98 | |
| 10-Day Volatility | 25.84% | |
| 1-Year Volatility | 60.37% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $578.90M | |
| EPS | $0.78 | |
| Gross Profit | $464.71M | |
| Gross Margin | 80.23% | |
| Operating Profit | $192.31M | |
| Operating Margin | 33.20% | |
| Net Income | $175.44M | |
| Net Margin | 30.30% | |
| EBITDA | $226.96M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| Current Ratio | 7.28 | |
| Quick Ratio | 7.27 | |
| Interest Coverage | - | |
| F-Score | 3 | |
| Altman Z-Score | 5.46 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 6.52 | |
| PS Ratio | 12.95 | |
| PB Ratio | 1.03 | |
| EV/EBITDA | -3.52 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $724.87M | |
| Cash & Equivalents | $501.29M | |
| Total Assets | $831.33M | |
| Current Assets | $547.77M | |
| Total Liabilities | $109.99M | |
| Current Liabilities | $75.28M | |
| Total Debt | $40.35M | |
| Short Term Debt | $5.54M | |
| Accounts Payable | $17.97M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $386.94M | |
| Operating Expenses | $272.39M | |
| Cost Of Goods Sold | $114.54M | |
| SG&A | $65.83M | |
| D&A | $20.36M | |
| Interest Expense | $0.00 | |
| Income Tax | $31.06M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $110.24M | |
| CFI | -$19.96M | |
| CFF | -$5.54M | |
| Capex | $19.96M | |
| Free Cash Flow | $90.28M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| UBS | → | |
| Jefferies | → | |
| JMP Securities | → | |
| UBS | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| Leerink Partners | → | |
| Guggenheim |
Analyst sentiment
Institutional ownership
Screeners with CVAC
Data Sources & References
- CVAC Official Website www.curevac.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1809122/000141057825000692/0001410578-25-000692-index.htm
- CVAC Profile on Yahoo Finance finance.yahoo.com/quote/CVAC
- CVAC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cvac
FAQ
What is the ticker symbol for CureVac N.V.?
The ticker symbol for CureVac N.V. is NASDAQ:CVAC
Does CureVac N.V. pay dividends?
No, CureVac N.V. does not pay dividends
What sector is CureVac N.V. in?
CureVac N.V. is in the Healthcare sector
What industry is CureVac N.V. in?
CureVac N.V. is in the Biotechnology industry
What country is CureVac N.V. based in?
CureVac N.V. is headquartered in Germany
When did CureVac N.V. go public?
CureVac N.V. initial public offering (IPO) was on August 14, 2020
Is CureVac N.V. in the S&P 500?
No, CureVac N.V. is not included in the S&P 500 index
Is CureVac N.V. in the NASDAQ 100?
No, CureVac N.V. is not included in the NASDAQ 100 index
Is CureVac N.V. in the Dow Jones?
No, CureVac N.V. is not included in the Dow Jones index
When was CureVac N.V. last earnings report?
CureVac N.V.'s most recent earnings report was on November 12, 2025
When does CureVac N.V. report earnings?
The next expected earnings date for CureVac N.V. is April 9, 2026